Literature DB >> 23142381

HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms.

Can Küçük1, Xiaozhou Hu, Javeed Iqbal, Philippe Gaulard, David Klinkebiel, Adam Cornish, Bhavana J Dave, Wing C Chan.   

Abstract

HACE1 is an E3 ubiquitin ligase located in 6q21, the genomic region frequently deleted in natural killer (NK) cell malignancies. Here, we report HACE1 as a candidate tumor suppressor gene silenced through a combination of deletion and cytosine phosphate guanine island hypermethylation. We detected deletion of HACE1 in malignant NK cell lines (6 of 9, 67%) and primary biopsies (5 of 15, 33%) by quantitative PCR, with most of the specimen showing cytosine phosphate guanine island hypermethylation in the remaining allele, leading to low mRNA transcription. The ectopic expression of HACE1 in an HACE1-null NK cell line led to apoptosis and G2/M cell cycle arrest. Moreover, HACE1 expression was up-regulated in IL-2-activated normal NK cells and NK cells cocultured with an engineered NK cell target, K562 Clone 9.mbIL21, suggesting its role in the regulation of NK cell homeostasis. In conclusion, HACE1 is another potent tumor suppressor gene located within the 6q21 region, and loss of function of multiple tumor suppressor genes within 6q21 may be a critical determinant of NK cell lymphomagenesis.
Copyright © 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23142381      PMCID: PMC3532710          DOI: 10.1016/j.ajpath.2012.09.012

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

1.  PRDM1 is a tumor suppressor gene in natural killer cell malignancies.

Authors:  Can Küçük; Javeed Iqbal; Xiaozhou Hu; Phillip Gaulard; Laurence De Leval; Gopesh Srivastava; Wing Yan Au; Timothy W McKeithan; Wing C Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

2.  Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas.

Authors:  Wayne Tam; Mario Gomez; Amy Chadburn; Joong W Lee; Wing C Chan; Daniel M Knowles
Journal:  Blood       Date:  2006-01-19       Impact factor: 22.113

3.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.

Authors:  C B Lozzio; B B Lozzio
Journal:  Blood       Date:  1975-03       Impact factor: 22.113

4.  IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12.

Authors:  Diederik van de Wetering; Roelof A de Paus; Jaap T van Dissel; Esther van de Vosse
Journal:  Int Immunol       Date:  2008-12-15       Impact factor: 4.823

5.  Rac1 is required for cell proliferation and G2/M progression.

Authors:  K A Moore; R Sethi; A M Doanes; T M Johnson; J B Pracyk; M Kirby; K Irani; P J Goldschmidt-Clermont; T Finkel
Journal:  Biochem J       Date:  1997-08-15       Impact factor: 3.857

6.  Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor.

Authors:  Zhenyu Yue; Shengkan Jin; Chingwen Yang; Arnold J Levine; Nathaniel Heintz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

Review 7.  The HECT family of E3 ubiquitin ligases: multiple players in cancer development.

Authors:  Francesca Bernassola; Michael Karin; Aaron Ciechanover; Gerry Melino
Journal:  Cancer Cell       Date:  2008-07-08       Impact factor: 31.743

8.  Aberrant methylation of the HACE1 gene is frequently detected in advanced colorectal cancer.

Authors:  Kenji Hibi; Makiko Sakata; Kazuma Sakuraba; Atsushi Shirahata; Tetsuhiro Goto; Hiroki Mizukami; Mitsuo Saito; Kazuyoshi Ishibashi; Gaku Kigawa; Hiroshi Nemoto; Yutaka Sanada
Journal:  Anticancer Res       Date:  2008 May-Jun       Impact factor: 2.480

9.  The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers.

Authors:  Liyong Zhang; Michael S Anglesio; Maureen O'Sullivan; Fan Zhang; Ge Yang; Renu Sarao; P Nghiem Mai; Shane Cronin; Hiromitsu Hara; Nataliya Melnyk; Liheng Li; Teiji Wada; Peter P Liu; Jason Farrar; Robert J Arceci; Poul H Sorensen; Josef M Penninger
Journal:  Nat Med       Date:  2007-08-12       Impact factor: 53.440

10.  Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells.

Authors:  Madeleine P Ball; Jin Billy Li; Yuan Gao; Je-Hyuk Lee; Emily M LeProust; In-Hyun Park; Bin Xie; George Q Daley; George M Church
Journal:  Nat Biotechnol       Date:  2009-03-29       Impact factor: 54.908

View more
  17 in total

1.  Bayesian Cox Proportional Hazards Model in Survival Analysis of HACE1 Gene with Age at Onset of Alzheimer's Disease.

Authors:  Ke-Sheng Wang; Ying Liu; Shaoqing Gong; Chun Xu; Xin Xie; Liang Wang; Xingguang Luo
Journal:  Int J Clin Biostat Biom       Date:  2017-12-01

2.  Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.

Authors:  Can Küçük; Bei Jiang; Xiaozhou Hu; Wenyan Zhang; John K C Chan; Wenming Xiao; Nathan Lack; Can Alkan; John C Williams; Kendra N Avery; Pınar Kavak; Anna Scuto; Emel Sen; Philippe Gaulard; Lou Staudt; Javeed Iqbal; Weiwei Zhang; Adam Cornish; Qiang Gong; Qunpei Yang; Hong Sun; Francesco d'Amore; Sirpa Leppä; Weiping Liu; Kai Fu; Laurence de Leval; Timothy McKeithan; Wing C Chan
Journal:  Nat Commun       Date:  2015-01-14       Impact factor: 14.919

3.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Hematolymphoid Tumours.

Authors:  Noah A Brown; Kojo S J Elenitoba-Johnson
Journal:  Head Neck Pathol       Date:  2017-02-28

4.  Genetic Architecture of Depression: Where Do We Stand Now?

Authors:  Pinar Unal-Aydin; Orkun Aydin; Ayla Arslan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma.

Authors:  Can Küçük; Xiaozhou Hu; Bei Jiang; David Klinkebiel; Huimin Geng; Qiang Gong; Alyssa Bouska; Javeed Iqbal; Philippe Gaulard; Timothy W McKeithan; Wing C Chan
Journal:  Clin Cancer Res       Date:  2015-01-22       Impact factor: 12.531

6.  Diagnostic and Biological Significance of KIR Expression Profile Determined by RNA-Seq in Natural Killer/T-Cell Lymphoma.

Authors:  Can Küçük; Xiaozhou Hu; Qiang Gong; Bei Jiang; Adam Cornish; Philippe Gaulard; Timothy McKeithan; Wing C Chan
Journal:  Am J Pathol       Date:  2016-04-07       Impact factor: 4.307

7.  Aberrant Rac pathway signalling in glioblastoma.

Authors:  Ian Aj Lorimer
Journal:  Small GTPases       Date:  2019-05-06

8.  The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate.

Authors:  Luigi Tortola; Roberto Nitsch; Mathieu J M Bertrand; Melanie Kogler; Younes Redouane; Ivona Kozieradzki; Iris Uribesalgo; Lilian M Fennell; Mads Daugaard; Helene Klug; Gerald Wirnsberger; Reiner Wimmer; Thomas Perlot; Renu Sarao; Shuan Rao; Toshikatsu Hanada; Nozomi Takahashi; Elisabeth Kernbauer; Duygu Demiröz; Michaela Lang; Giulio Superti-Furga; Thomas Decker; Andrea Pichler; Fumiyo Ikeda; Guido Kroemer; Peter Vandenabeele; Poul H Sorensen; Josef M Penninger
Journal:  Cell Rep       Date:  2016-05-05       Impact factor: 9.423

9.  PRDM1 decreases sensitivity of human NK cells to IL2-induced cell expansion by directly repressing CD25 (IL2RA).

Authors:  Burcu Akman; Xiaozhou Hu; Xuxiang Liu; Tevfik Hatipoğlu; Hua You; Wing C Chan; Can Küçük
Journal:  J Leukoc Biol       Date:  2020-11-04       Impact factor: 4.962

10.  The Genetic Deletion of 6q21 and PRDM1 and Clinical Implications in Extranodal NK/T Cell Lymphoma, Nasal Type.

Authors:  Li Liang; Zhang Zhang; Ying Wang; Lin Nong; Yalin Zheng; Linlin Qu; Bo Zhang; Ting Li
Journal:  Biomed Res Int       Date:  2015-06-29       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.